Methods of suppressing microglial activation

Details for Australian Patent Application No. 2008202920 (hide)

Owner Cognosci, Inc.

Inventors Laskowitz, Daniel T; McMillian, Michael; Matthew, William D

Agent Davies Collison Cave

Pub. Number AU-B-2008202920

Parent 2002341739

Filing date 2 July 2008

Wipo publication date 31 July 2008

Acceptance publication date 20 January 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61B 1/00 (2006.01) Diagnosis

A61K 31/13 (1970.01) - Amines, e.g. amantadine

A61K 31/19 (2006.01)

A61K 31/197 (2006.01)

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/515 (1970.01)

A61K 31/52 (1970.01)

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 23/00 Anaesthetics

Event Publications

24 July 2008 Complete Application Filed

31 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202920

20 January 2011 Application Accepted

  Published as AU-B-2008202920

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202921-Combined prime valve and electrical pressure control for paint spray pumps

2008202919-Method and system for providing relevant coupons to consumers based on financial transaction history and internet browsing activity